Rallybio Corporation (RLYB)
Develops experimental medicines to treat rare genetic and blood disorders.
$16.16-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+277.5%
The outlook
RLYB is trading near the top of its 52-week range and above both its 50- and 200-day moving averages, reflecting an uptrend. The stock sits in the upper part of its recent price zone with minimal movement today. Analyst coverage appears thin, so detailed rating and target data are unavailable.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range90% of the way from its 52-week low to high
Market cap
$85.7M
52-wk high
$17.57
52-wk low
$3.20
50-day avg
$15.74
200-day avg
$9.06
Trailing P/E
—